000 01781 a2200493 4500
005 20250514210541.0
264 0 _c20041227
008 200412s 0 0 eng d
022 _a0027-8424
024 7 _a10.1073/pnas.0407297101
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMiura, Yutaka
245 0 0 _aReversion of the Jun-induced oncogenic phenotype by enhanced synthesis of sialosyllactosylceramide (GM3 ganglioside).
_h[electronic resource]
260 _bProceedings of the National Academy of Sciences of the United States of America
_cNov 2004
300 _a16204-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnimals
650 0 4 _aAntigens, CD
_xmetabolism
650 0 4 _aBase Sequence
650 0 4 _aCell Adhesion
650 0 4 _aCell Division
650 0 4 _aCell Line, Transformed
650 0 4 _aChick Embryo
650 0 4 _aDown-Regulation
650 0 4 _aG(M3) Ganglioside
_xbiosynthesis
650 0 4 _aGenes, jun
650 0 4 _aIntegrin alpha5beta1
_xmetabolism
650 0 4 _aMembrane Glycoproteins
_xmetabolism
650 0 4 _aMice
650 0 4 _aMolecular Sequence Data
650 0 4 _aOncogene Protein p65(gag-jun)
_xphysiology
650 0 4 _aPhenotype
650 0 4 _aRNA, Messenger
_xgenetics
650 0 4 _aSialyltransferases
_xgenetics
650 0 4 _aTetraspanin 29
650 0 4 _aTransfection
700 1 _aKainuma, Mami
700 1 _aJiang, Hao
700 1 _aVelasco, Hershey
700 1 _aVogt, Peter K
700 1 _aHakomori, Senitiroh
773 0 _tProceedings of the National Academy of Sciences of the United States of America
_gvol. 101
_gno. 46
_gp. 16204-9
856 4 0 _uhttps://doi.org/10.1073/pnas.0407297101
_zAvailable from publisher's website
999 _c15221666
_d15221666